ConductScience.org, home

Paper33086751

The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease.

Bukke VN and 8 others. Int J Mol Sci, 2020. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease. Papers, record 33086751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33086751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.15
iCite
Revised in PubMed
2021-02-23
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bukke VNVidyasagar Naik
2Villani RRosannahttps://orcid.org/0000-0001-9875-019X
3Archana MMoola
4Wawrzyniak AAgata
5Balawender KKrzysztofhttps://orcid.org/0000-0002-8706-1927
6Orkisz SStanislawhttps://orcid.org/0000-0002-8526-2311
7Ferraro LLuca
8Serviddio GGaetano
9Cassano TTommasohttps://orcid.org/0000-0001-6330-806X

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
GlucoseMajor topic
Metabolic Networks and PathwaysMajor topic
Molecular Targeted TherapyMajor topic
Animals
Glycosylation
Humans
Models, Biological

Source PubMed

Download CSV of topics

References117

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130693278Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety.Front Chem2018https://conductscience.org/library/papers/30693278PubMed
211788610Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.J Biol Chem2002https://conductscience.org/library/papers/11788610PubMed
316412100Sialylation enhances the secretion of neurotoxic amyloid-beta peptides.J Neurochem2006https://conductscience.org/library/papers/16412100PubMed
430738142Loss of biliverdin reductase-A favors Tau hyper-phosphorylation in Alzheimer's disease.Neurobiol Dis2019https://conductscience.org/library/papers/30738142PubMed
528465241N-glycan and Alzheimer's disease.Biochim Biophys Acta Gen Subj2017https://conductscience.org/library/papers/28465241PubMed
615249677O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.Proc Natl Acad Sci U S A2004https://conductscience.org/library/papers/15249677PubMed
729576849Palmitoylethanolamide Dampens Reactive Astrogliosis and Improves Neuronal Trophic Support in a Triple Transgenic Model of Alzheimer's Disease: In Vitro and In Vivo Evidence.Oxid Med Cell Longev2018https://conductscience.org/library/papers/29576849PubMed
812941958Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.J Biol Chem2003https://conductscience.org/library/papers/12941958PubMed
918587388A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo.Nat Chem Biol2008https://conductscience.org/library/papers/18587388PubMed
10275708712016 Alzheimer's disease facts and figures.Alzheimers Dement2016https://conductscience.org/library/papers/27570871PubMed
1111148210Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.J Biol Chem2001https://conductscience.org/library/papers/11148210PubMed
1223791707γ-Secretase inhibitors and modulators.Biochim Biophys Acta2013https://conductscience.org/library/papers/23791707PubMed
1324409422Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies.Clin Transl Imaging2013https://conductscience.org/library/papers/24409422PubMed
142137449Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.J Biol Chem1990https://conductscience.org/library/papers/2137449PubMed
1510993067Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing.Nature2000https://conductscience.org/library/papers/10993067PubMed
169497354
Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism.
J Biol Chem1998https://conductscience.org/library/papers/9497354PubMed
1729460617Pharmacological Inhibition of O-GlcNAcase Enhances Autophagy in Brain through an mTOR-Independent Pathway.ACS Chem Neurosci2018https://conductscience.org/library/papers/29460617PubMed
1817227027Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.J Am Chem Soc2007https://conductscience.org/library/papers/17227027PubMed
1927703002Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis.J Biol Chem2016https://conductscience.org/library/papers/27703002PubMed
2012668248Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices.Neurosci Lett2003https://conductscience.org/library/papers/12668248PubMed

See all 117 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42280440Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.Nutrients2026https://conductscience.org/library/papers/42280440PubMed
41462898Unlocking the Sugar Code: Implications and Consequences of Glycosylation in Alzheimer's Disease and Other Tauopathies.Biomedicines2025https://conductscience.org/library/papers/41462898PubMed
40903936O-GlcNAcylation: A molecular switch linking brain health to neurodegeneration.Neural Regen Res2026https://conductscience.org/library/papers/40903936PubMed
40336061Invasive laser acupuncture targeting muscle: a novel approach to protect dopaminergic neurons and reduce neuroinflammation in a brain of Parkinson's disease model.Chin Med2025https://conductscience.org/library/papers/40336061PubMed
39765914Oxidative Stress, Inflammation and Altered Glucose Metabolism Contribute to the Retinal Phenotype in the Choroideremia Zebrafish.Antioxidants (Basel)2024https://conductscience.org/library/papers/39765914PubMed
38946780The alteration and role of glycoconjugates in Alzheimer's disease.Front Aging Neurosci2024https://conductscience.org/library/papers/38946780PubMed
38516320In Silico Localization of Perilymph Proteins Enriched in Meńier̀e Disease Using Mammalian Cochlear Single-cell Transcriptomics.Otol Neurotol Open2023https://conductscience.org/library/papers/38516320PubMed
37662613Agent Orange Causes Metabolic Dysfunction and Molecular Pathology Reminiscent of Alzheimer's Disease.J Alzheimers Dis Rep2023https://conductscience.org/library/papers/37662613PubMed
37626031New insight into protein glycosylation in the development of Alzheimer's disease.Cell Death Discov2023https://conductscience.org/library/papers/37626031PubMed
37415097Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives.Mol Med2023https://conductscience.org/library/papers/37415097PubMed
36877359The Involvement of Post-Translational Modifications in Regulating the Development and Progression of Alzheimer's Disease.Mol Neurobiol2023https://conductscience.org/library/papers/36877359PubMed
36606272Critical appraisal on mitochondrial dysfunction in Alzheimer's disease.Aging Med (Milton)2022https://conductscience.org/library/papers/36606272PubMed
36408104Identification and immune characteristics of molecular subtypes related to protein glycosylation in Alzheimer's disease.Front Aging Neurosci2022https://conductscience.org/library/papers/36408104PubMed
35686025
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease.
Front Aging Neurosci2022https://conductscience.org/library/papers/35686025PubMed
34916409Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury.Neural Regen Res2022https://conductscience.org/library/papers/34916409PubMed

Download CSV of cited by

Genes13

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33086751

GET https://conductscience.org/api/papers/v1/33086751/references?page=2